DiaMedica Therapeutics Inc.
NASDAQ:DMACBiotechnology
Healthcare
$8.38 -0.17%
-$0.01 today
- Market cap
- $452.16M
- Beta
- 1.00
- P/E (TTM)
- -8.8
- EPS (TTM)
- -$0.65
52W Low $3.48High $10.42
Volume 0.29M
Average 0.19M
Price history
DiaMedica Therapeutics Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+21.45%
Period high
$10.77
Period low
$5.33
Latest
$8.38
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Aug 12, 2026 | Aug 12, 2026 | |
| S-8 | Aug 11, 2026 | Aug 11, 2026 | |
| 10-Q | Aug 10, 2026 | Aug 10, 2026 | |
| 8-K | Aug 10, 2026 | Aug 10, 2026 | |
| 4 | Jun 3, 2026 | Jun 3, 2026 | |
| 4 | Jun 3, 2026 | Jun 3, 2026 | |
| 4 | Jun 3, 2026 | Jun 3, 2026 | |
| 4 | Jun 3, 2026 | Jun 3, 2026 | |
| 4 | Jun 3, 2026 | Jun 3, 2026 | |
| 4 | Jun 3, 2026 | Jun 3, 2026 | |
| 4 | Jun 3, 2026 | Jun 3, 2026 | |
| 4 | Jun 3, 2026 | Jun 3, 2026 | |
| 4 | Jun 3, 2026 | Jun 3, 2026 |
Competitors
Who does DiaMedica Therapeutics Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about DMAC's filings, answered from its disclosures.
What is the latest DMAC filing?
The latest filing shown is 8-K dated Nov 12, 2026.
How many recent filings does DMAC have?
Intrinsic Alpha currently shows 20 recent filings for DMAC.
Continue the stock analysis
Jump to another research area for this company.